1. Cytokine effects on glutamate uptake by human astrocytes.
- Author
-
Hu S, Sheng WS, Ehrlich LC, Peterson PK, and Chao CC
- Subjects
- Biological Transport drug effects, Cells, Cultured, Drug Synergism, Fetus, Humans, Inflammation, Interleukin 1 Receptor Antagonist Protein, Nitric Oxide physiology, Recombinant Proteins pharmacology, omega-N-Methylarginine pharmacology, Astrocytes metabolism, Glutamic Acid metabolism, Interferon-beta pharmacology, Interferon-gamma pharmacology, Interleukin-1 pharmacology, Sialoglycoproteins pharmacology, Tumor Necrosis Factor-alpha pharmacology
- Abstract
Glutamate uptake by astrocytes has been postulated to play a neuroprotective role during brain inflammation. Using primary human fetal astrocyte cultures, we investigated the influence of selected cytokines on glutamate uptake activity. Interleukin (IL)-1beta and tumor necrosis factor-alpha dose-dependently inhibited astrocyte glutamate uptake, whereas interferon (IFN)-gamma alone stimulated this activity. The nitric oxide synthase inhibitor, N(G)-monomethyl-L-arginine, blocked IL-1beta-mediated inhibition of glutamate uptake, suggesting involvement of nitric oxide in the effect of IL-1beta. IL-1 receptor antagonist protein totally reversed the inhibitory effect of cytokines, suggesting a critical role of IL-1beta. The anti-inflammatory cytokine IFN-beta blocked cytokine (IL-1beta plus IFN-gamma)-induced inhibition of glutamate uptake with a corresponding reduction in nitric oxide generation. Taken together, these findings suggest that proinflammatory cytokines inhibit astrocyte glutamate uptake by a mechanism involving nitric oxide, and that IFN-beta may exert a therapeutically beneficial effect by blocking cytokine-induced nitric oxide production in inflammatory diseases of the brain., (Copyright 2000 S. Karger AG, Basel)
- Published
- 2000
- Full Text
- View/download PDF